This inventor holds 18 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Ssp Co. Ltd, Ss Pharmaceutical Co., Ltd., Hisamitsu Medical Co., Ltd.. Active years: 1995-2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ichihara, JP (1995 - 2001)
- Narita, JP (2001)
- Chiba, JP (2004 - 2005)
Company Filing History:
9 out of 27 
8 out of 90 
1 out of 1 Years Active: 1995-2005
Areas of Expertise:
Title: The Innovative Contributions of Sunao Takeda
Introduction
Sunao Takeda, an esteemed inventor based in Ichihara, Japan, has significantly contributed to the field of pharmaceuticals through his groundbreaking research and development. With a total of 18 patents to his name, Takeda's work focuses predominantly on imidazole derivatives and their therapeutic applications.
Latest Patents
Among his latest innovations is a patent pertaining to imidazole derivatives or salts thereof, designed to address various medical conditions. The invention is represented by a specific formula where each component signifies a unique structure, including R, A, X, Y, and Z, which are integral to the compound's function. These compounds are particularly notable for their ability to inhibit the production of nitric oxide (NO) and interleukin-6 (IL-6), making them potential candidates for preventing or treating diseases that arise from their overproduction. Additionally, Takeda has developed pharmaceuticals that contain these imidazole derivatives, highlighting their utility in modern medicine.
Career Highlights
Throughout his career, Takeda has worked with several prominent companies, including SSP Co. Ltd. and SS Pharmaceutical Co., Ltd. His ongoing research and innovations have led to 18 patents, reflecting his dedication to advancing drug development and improving therapeutic outcomes for various health conditions.
Collaborations
Throughout his journey, Takeda has collaborated with notable colleagues such as Takemitsu Asaoka and Susumu Sato. These partnerships have facilitated the exchange of ideas and expertise, further propelling advancements in imidazole derivatives and their applications in medicine.
Conclusion
Sunao Takeda’s contributions to the field of pharmaceuticals through his patents and innovations exemplify the importance of research in developing new therapeutic agents. His work continues to pave the way for potential breakthroughs in treating diseases linked to the overproduction of key biological mediators. As a leading inventor, Takeda's legacy serves as an inspiration to future generations of researchers and inventors.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile